Stay updated on Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial

Sign up to get notified when there's something new on the Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:35:42.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    No additions or deletions observed; the page content and layout appear unchanged between versions.
    Difference
    0.1%
    Check dated 2026-04-09T08:01:03.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added the alias 'Severe myoclonic epilepsy in infancy' to the Conditions section to reflect SMEI/Dravet terminology.
    Difference
    0.1%
    Check dated 2026-04-02T00:23:42.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Removed 'Dravet syndrome' from the list of conditions on the Study Details page.
    Difference
    0.0%
    Check dated 2026-03-25T20:50:52.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The site version updated from v3.4.3 to v3.5.0, with no visible changes to the Study Details page.
    Difference
    0.1%
    Check dated 2026-03-18T16:48:42.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T14:43:10.000Z thumbnail image

Stay in the know with updates to Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial page.